Peter Soparkar, See Remarks section at Adverum Biotechnologies, Inc. (ADVM), bought 25,000 shares at $1.91 ($48K) on 2021-12-08, disclosed to the SEC on 2021-12-10.
Open-market purchase of $48k ADVM by See Remarks section. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| Filing → |
| ADVM | SELL | 2023-03-17 | $10K | — | Filing → |
| ADVM | SELL | 2022-09-21 | $14K | — | Filing → |
| ADVM | BUY | 2022-04-20 | $25K | — | Filing → |